These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11941110)

  • 1. Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome.
    Davis JM; Janicak PG; Sakkas P; Gilmore C; Wang Z
    Convuls Ther; 1991; 7(2):111-120. PubMed ID: 11941110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Choice in Neuroleptic Malignant Syndrome.
    Scheftner WA; Shulman RB
    Convuls Ther; 1992; 8(4):267-279. PubMed ID: 11941178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment of the neuroleptic malignant syndrome.
    Sakkas P; Davis JM; Janicak PG; Wang ZY
    Psychopharmacol Bull; 1991; 27(3):381-4. PubMed ID: 1685592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic Malignant Syndrome: Neuroleptic Rechallenge After Electroconvulsive Therapy.
    Hanin B; Lerner Y
    Convuls Ther; 1993; 9(3):198-204. PubMed ID: 11941213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroleptic malignant syndrome-a systematic case series analysis focusing on therapy regimes and outcome.
    Kuhlwilm L; Schönfeldt-Lecuona C; Gahr M; Connemann BJ; Keller F; Sartorius A
    Acta Psychiatr Scand; 2020 Sep; 142(3):233-241. PubMed ID: 32659853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroconvulsive Therapy of the Lethal Catatonia Syndrome.
    Mann SC; Caroff SN; Bleier HR; Antelo RE; Un H
    Convuls Ther; 1990; 6(3):239-247. PubMed ID: 11941074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report.
    Katzell L; Beydler E; Dos Santos AS; Vijayvargiya R; Carr BR
    Front Psychiatry; 2023; 14():1143407. PubMed ID: 37032940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive Therapy in the Neuroleptic Malignant Syndrome.
    Casey DA
    Convuls Ther; 1987; 3(4):278-283. PubMed ID: 11940929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome in Mexico.
    Montoya A; Ocampo M; Torres-Ruiz A
    Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified ECT Using Succinylcholine After Remission of Neuroleptic Malignant Syndrome.
    Devanand DP; Sackeim HA; Finck AD
    Convuls Ther; 1987; 3(4):284-290. PubMed ID: 11940930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
    Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahastrabuddhe GS
    J Assoc Physicians India; 2008 Jan; 56():49-50. PubMed ID: 18472502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AANA journal course. Update for nurse anesthetists. Neuroleptic malignant syndrome.
    Waldorf S
    AANA J; 2003 Oct; 71(5):389-94. PubMed ID: 14625976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
    Kucia K; Warchala A
    Wiad Lek; 2005; 58(9-10):572-4. PubMed ID: 16529073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroconvulsive Therapy for Neuroleptic Malignant Syndrome: A Case Series.
    Morcos N; Rosinski A; Maixner DF
    J ECT; 2019 Dec; 35(4):225-230. PubMed ID: 31764444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroleptic malignant syndrome: a life-threatening complication that can be treated effectively].
    van Waarde JA; Muller ME; Verweg B
    Ned Tijdschr Geneeskd; 2006 Nov; 150(46):2517-20. PubMed ID: 17152323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.